Thomas J. Arista

FDA investigator · also recorded as J. Arista

Appears on 21 documents from 2001 to 2022, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

21
Documents on file
12.8
Observations per 483
2001
First seen
2022
Most recent

What they cite most

From 169 observations

Activity by year

2001: 2, 2009: 2, 2011: 1, 2013: 4, 2014: 1, 2015: 2, 2016: 1, 2019: 4, 2022: 4

Where

India 10 · California 4 · Indiana 2 · Massachusetts 1 · Missouri 1 · North Carolina 1

Is Thomas J. Arista coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

21 documents, newest first
FirmOpen
483 Amneal Pharmaceuticals Private LimitedDec 23, 2022 · Ahmedabad, India
483 Lupin Limited Unit 1Nov 23, 2022 · Mandideep, India
483 Maiva Pharma Private LimitedOct 29, 2022 · Hosur, India
483 Mylan Laboratories LimitedSep 23, 2022 · Hosur, India
483 EUGIA PHARMA SPECIALITIES LIMITEDNov 13, 2019 · Sangareddy, India
483 Cipla LimitedSep 27, 2019 · Vasco Da Gama, India
483 Dr. Reddy's Laboratories Ltd. | P21 - P9 Vsez, Q1 - Q5 Phase IiiAug 20, 2019 · Duvvada, India

About this profile

What does Thomas J. Arista inspect?

Thomas J. Arista appears on 21 documents on file covering 20 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Thomas J. Arista is dated Dec 23, 2022.